Ximelagatran and melagatran vs. low-molecular-weight heparin in major orthopedic surgery: relationship between efficacy and safety and timing of initial administration.

P. Zufferey; S. Laporte; S. Molliex; C. Auboyer; P. Mismetti

doi:10.1111/j.1538-7836.2005.01318.x

Journal Articles Journal of Thrombosis and Haemostasis Year : 2005

Ximelagatran and melagatran vs. low-molecular-weight heparin in major orthopedic surgery: relationship between efficacy and safety and timing of initial administration.

(1) , (1) , , , (1)

1

P. Zufferey

Function : Author

Groupe de recherche sur la thrombose

S. Laporte

Function : Author

Groupe de recherche sur la thrombose

S. Molliex

Function : Author

C. Auboyer

Function : Author

P. Mismetti

Function : Author

Groupe de recherche sur la thrombose

Domains

Life Sciences [q-bio] Pharmaceutical sciences Pharmacology

Patrick Mismetti : Connect in order to contact the contributor

https://hal-ujm.archives-ouvertes.fr/ujm-00439804

Submitted on : Tuesday, December 8, 2009-3:38:17 PM

Last modification on : Monday, December 12, 2022-5:26:11 PM

Dates and versions

ujm-00439804 , version 1 (08-12-2009)

Identifiers

HAL Id : ujm-00439804 , version 1
DOI : 10.1111/j.1538-7836.2005.01318.x
PUBMED : 15869622

Cite

P. Zufferey, S. Laporte, S. Molliex, C. Auboyer, P. Mismetti. Ximelagatran and melagatran vs. low-molecular-weight heparin in major orthopedic surgery: relationship between efficacy and safety and timing of initial administration.. Journal of Thrombosis and Haemostasis, 2005, 3 (5), pp.1104-7. ⟨10.1111/j.1538-7836.2005.01318.x⟩. ⟨ujm-00439804⟩

Export

BibTeX TEI Dublin Core DC Terms EndNote Datacite

Collections

UNIV-ST-ETIENNE UDL

7 View

0 Download

Ximelagatran and melagatran vs. low-molecular-weight heparin in major orthopedic surgery: relationship between efficacy and safety and timing of initial administration.

Domains

Dates and versions

Identifiers

Cite

Export

Collections

Altmetric

Share